“As oseltamivir is the most widely used therapeutic and prophylactic against IAV, the continued circulation of viruses ...

COVID and the 1918 flu pandemic gave us playbooks on how to prepare for the next pandemic. But we aren’t using it.

Flu Virus Variants Resistant to New Antiviral Drug Candidate Lose Pathogenicity Feb. 6, 2024 — Influenza A viruses with induced resistance to a new candidate antiviral drug were found to be ...

CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

The findings come at a time when outbreaks of bird flu -- a different subtype of the ... Study Shows Drop in Use of Antiviral Medications in Young Children With Influenza Dec. 17, 2024 — Despite ...

Guideline-recommended influenza-specific antivirals were only prescribed in approximately half of children hospitalized with influenza.

Between the 2017-2018 and 2023-2024 influenza seasons, the use of antiviral therapy in pediatric patients with influenza declined in both inpatient and outpatient settings.

He advised that if the flu is confirmed through testing, it can be treated with antiviral medications. However, Dr. Blatt warned that if symptoms worsen instead of improving, it could indicate a ...

Eradivir is a Purdue Strategic Ventures portfolio company. Eradivir’s goal is to focus the power of the immune system to treat disease. The company is developing the BAiT platform (Bispecific ...

Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25. The study will provide safety and ...